Vertex Pharmaceuticals Incorporated shares owned by Vantage Consulting Group
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Vantage Consulting Group
from 13F filings
Historical chart of Vantage Consulting Group investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Vantage Consulting Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Vantage Consulting Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $271k | 666 | 406.89 |
| 2023-09-30 | $236k | 678 | 347.74 |
| 2023-06-30 | $243k | 690 | 351.91 |
| 2023-03-31 | $263k | 835 | 315.07 |
| 2022-12-31 | $223k | 772 | 288.78 |
| 2022-09-30 | $253k | 875 | 289.14 |
| 2022-06-30 | $266k | 945 | 281.48 |
| 2022-03-31 | $254k | 972 | 261.32 |
| 2021-12-31 | $275k | 1.3k | 219.65 |
| 2021-09-30 | $234k | 1.3k | 181.11 |
| 2021-06-30 | $237k | 1.2k | 201.36 |
| 2020-12-31 | $76k | 322 | 236.02 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated